Caspase-3 in Brain Death Donors Is Associated with Reduced Primary Graft Dysfunction After Heart Transplantation
Authors:
- Lorena HerradorLHLorena Herrador
- José González-CostelloJGJosé González-Costello
- Jordi Niubo-BoschJNJordi Niubo-Bosch
- Laura Calatayud-SamperLCLaura Calatayud-Samper
- Alba Maestro-BenedictoAMAlba Maestro-Benedicto
- Marta Farrero-TorresMFMarta Farrero-Torres
- Teresa Blasco-PeiroTBTeresa Blasco-Peiro
- Luis Almenar-BonetLALuis Almenar-Bonet
- Zorba Blázquez-BermejoZBZorba Blázquez-Bermejo
- Iris Garrido-BravoIGIris Garrido-Bravo
- Ferran Gran-IpiñaFGFerran Gran-Ipiña
- Antonio Grande-TrilloAGAntonio Grande-Trillo
Open Access
- 26 September 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (19) , 9434
Abstract
Primary graft dysfunction (PGD) remains a major cause of early morbidity and mortality after a heart transplant (HTx). Understanding the donor-related mechanisms involved may help improve organ selection and post-HTx outcomes. This study aimed to explore the association between the donor serum biomarkers of cell death and inflammation and the incidence of PGD and rejection in HTx recipients. We conducted a retrospective, multicenter observational study of brain-dead (DBD) heart donors and corresponding recipients between 2013 and 2019. Donor blood samples were analyzed for inflammatory cytokines, cell death-related proteins, and mitochondrial (mtDNA) and genomic DNA (gDNA). A total of 39 donor–recipient pairs were included. Sixteen recipients developed severe PGD, and five experienced ≥2R cellular rejection. Donors whose recipients developed PGD had significantly lower serum Caspase-3 levels compared to those without PGD (391.6 [101.8–1003.3] vs. 65.3 [40.2–163.3] pg/mL; p = 0.04). A trend toward lower mtDNA/gDNA ratio was also observed in the same group (10.5 [5.4–24.6] vs. 6.5 [3.3–10.7]; p = 0.067). Lower Caspase-3 levels in donor serum were significantly associated with the development of severe PGD in recipients. This may suggest that the sublethal activation of apoptotic pathways in the donor could play a protective role, potentially conditioning the graft to tolerate ischemic injury.Keywords
Funding Information
- Hospital Universitari de Bellvitge and Bellvitge Biomedical Research Institute (PR066/17)
This publication has 37 references indexed in Scilit:
- The International Consortium on Primary Graft Dysfunction: Redefining Clinical Risk Factors in the Contemporary Era of Heart TransplantationJournal of Cardiac Failure, 2023
- Mechanical circulatory support in severe primary graft dysfunction: Peripheral cannulation but not earlier implantation improves survival in heart transplantationThe Journal of Heart and Lung Transplantation, 2023
- The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult heart transplantation report — 2021; Focus on recipient characteristicsThe Journal of Heart and Lung Transplantation, 2021
- Serum biomarkers of acute rejection: Towards precision medicine in heart transplantThe Journal of Heart and Lung Transplantation, 2021
- Roles of inflammation and apoptosis in experimental brain death–induced right ventricular failureThe Journal of Heart and Lung Transplantation, 2016
- Report from a consensus conference on primary graft dysfunction after cardiac transplantationThe Journal of Heart and Lung Transplantation, 2014
- Molecular markers of programmed cell death in donor hearts before transplantationThe Journal of Heart and Lung Transplantation, 2014
- Predicting acute cardiac rejection from donor heart and pre-transplant recipient blood gene expressionThe Journal of Heart and Lung Transplantation, 2013
- Revision of the 1990 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Heart RejectionThe Journal of Heart and Lung Transplantation, 2005
- Blood levels of cytokines in brain-dead patients: Relationship with circulating hormones and acute-phase reactantsMetabolism, 1995